MedTrace Logo

Study of FemVue(TM) Sono Tubal Evaluation System Method Comparison to HSG

NCT01053052 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2017-05-09

No results posted yet for this study

Summary

Multi-center prospective comparison of fallopian tubal patency determination and uterine evaluation interventions using legally marketed devices for their intended purposes, and using each subject as their own control.

Conditions

  • Fallopian Tube Patency Tests

Interventions

DEVICE

Sonography with FemVue, and HSG

Sono HSG for FDA 510(k) cleared indication for use

Sponsors & Collaborators

  • Femasys Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2013-01-31
Completion
2013-01-31
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01053052 on ClinicalTrials.gov